PGP(a-13:0/18:2(9Z,11Z)) (BioCAD00000110736)
{$topic}
Metabolite Card
Formula: C37H70O13P2 (784.4291)
SMILES: [H][C@](O)(COP(O)(O)=O)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCC\C=C/C=C\CCCCCC
Synonyms [en]
[(2S)-2-Hydroxy-3-({hydroxy[(2R)-3-[(10-methyldodecanoyl)oxy]-2-[(9Z,11Z)-octadeca-9,11-dienoyloxy]propoxy]phosphoryl}oxy)propoxy]phosphonate; PGP(a-13:0/18:2(9Z,11Z)); PGP(a-13:0/18:2n7); 1-anteisotridecanoyl-2-(9Z,11Z)-octadecadienoyl-sn-glycero-3-phospho-(1'-sn-glycerol-3'-phosphate); PGP(a-13:0/18:2w7); PGP(a-13:0/18:2)
Last reviewed on 2024-06-28.
Cite this Page
PGP(a-13:0/18:2(9Z,11Z)). 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000110736). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
PGP(a-13:0/18:2(9Z,11Z)) is a phosphatidylglycerophosphate (PGP). It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site followed by another phosphate moiety. Phosphatidylglycerolphosphate is present at a level of 1-2% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant (up to 11% of the total). It is well established that the concentration of phosphatidylglycerolphosphate increases during fetal development. Phosphatidylglycerolphosphate may be present in animal tissues merely as a precursor for cardiolipin synthesis. As is the case with diacylglycerols, phosphatidylglycerophosphates can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PGP(a-13:0/18:2(9Z,11Z)), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of (9Z,11Z)-octadecadienoic acid at the C-2 position. They are synthesized by the addition of glycerol 3-phosphate to a CDP-diacylglycerol. In turn, PGPs are dephosphorylated to phosphatidylglycerols (PGs). While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes.
DBLinks
- CAS Registry Number:
- PubChem CID: 131823168
- ChEBI:
- HMDB: HMDB0116513
- LipidMaps:
- KEGG:
- BioCyc:
- NCBI MeSH:
- Wikipedia:
Other DBLinks
- PubChem: 131823168
- HMDB: HMDB0116513
Class / Ontology
- WishartLab ClassyFire: [Glycerophosphoglycerophosphates] Glycerophosphoglycerophosphates
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| PathBank:SMP0043325 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/18:2(9Z,11Z)/a-17:0) |
| PathBank:SMP0043329 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/18:2(9Z,11Z)/i-13:0) |
| PathBank:SMP0043333 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/18:2(9Z,11Z)/i-17:0) |
| PathBank:SMP0043337 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/18:2(9Z,11Z)/i-21:0) |
| PathBank:SMP0043341 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-13:0/a-13:0) |
| PathBank:SMP0043345 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-13:0/a-25:0) |
| PathBank:SMP0043349 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-13:0/i-15:0) |
| PathBank:SMP0043353 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-13:0/i-19:0) |
| PathBank:SMP0043357 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-13:0/i-24:0) |
| PathBank:SMP0043361 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-15:0/a-17:0) |
| PathBank:SMP0043365 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-15:0/i-13:0) |
| PathBank:SMP0043369 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-15:0/i-17:0) |
| PathBank:SMP0043373 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-15:0/i-21:0) |
| PathBank:SMP0043377 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-17:0/a-13:0) |
| PathBank:SMP0043381 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-17:0/a-25:0) |
| PathBank:SMP0043385 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-17:0/i-15:0) |
| PathBank:SMP0043389 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-17:0/i-20:0) |
| PathBank:SMP0043393 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-21:0/18:2(9Z,11Z)) |
| PathBank:SMP0043397 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-21:0/a-21:0) |
| PathBank:SMP0043401 | Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/a-21:0/i-14:0) |